AAN: New guideline on how to best treat involuntary movements in Huntington's disease

July 18, 2012

A new guideline released by the American Academy of Neurology recommends several treatments for people with Huntington's disease who experience chorea—jerky, random, uncontrollable movements that can make everyday activities challenging. The guideline is published in the July 18, 2012, online issue of Neurology.

"Chorea can be disabling, worsen weight loss and increase the risk of falling," said guideline lead author Melissa Armstrong, MD, MSc, with the University of Maryland Department of and a member of the American Academy of Neurology.

is a complex disease with physical, cognitive and behavioral symptoms. The new guideline addresses only one aspect of the disease that may require treatment.

The guideline found that the drugs tetrabenazine (TBZ), riluzole and amantadine can be helpful and the nabilone may also be considered to treat chorea. The medications riluzole, amantadine and nabilone are not often prescribed for Huntington's disease.

"People with Huntington's disease who have chorea should discuss with their doctors whether treating chorea is a priority. Huntington's disease is complex with a wide range of sometimes severe symptoms and treating other may be a higher priority than treating chorea," said Armstrong.

Armstrong adds that it is important for patients to understand that their doctors may try drugs not recommended in this guideline to treat chorea. More research is needed to know if drugs such as those used for psychosis are effective; however, doctors may prescribe them on the basis of past clinical experience.

Explore further: Worried about family or friends falling? New guideline identifies those most at risk

More information: Learn more about the guideline at www.aan.com/guidelines or Huntington's disease at www.aan.com/patients

Related Stories

FDA approves first drug for Huntington's disease

August 16, 2008

The U.S. Food and Drug Administration today approved tetrabenazine, the first drug approved for use in the United States to treat Huntington's disease, a fatal, inherited neurodegenerative disorder for which there is no cure. ...

AAN guideline evaluates treatments for muscle cramps

February 22, 2010

A new guideline from the American Academy of Neurology recommends that the drug quinine, although effective, should be avoided for treatment of routine muscle cramps due to uncommon but serious side effects. The guideline ...

AAN releases updated guideline for treating essential tremor

October 19, 2011

The American Academy of Neurology is releasing an updated guideline on how to best treat essential tremor, which is the most common type of tremor disorder and is often confused with other movement disorders such as Parkinson's ...

Recommended for you

Amputees' brains remember missing hands even years later

August 30, 2016

Our brains have a detailed picture of our hands and fingers, and that persists even decades after an amputation, Oxford University researchers have found. The finding could have implications for the control of next generation ...

Brain's internal compass also navigates during imagination

August 30, 2016

When you try to find your way in a new place, your brain creates a spatial map that represents that environment. Neuroscientists from Radboud University's Donders Institute now show that the brain's 'navigation system' is ...

Special nerve cells cause goose bumps and nipple erection

August 29, 2016

The sympathetic nerve system has long been thought to respond the same regardless of the physical or emotional stimulus triggering it. However, in a new study from Karolinska Institutet published in the Nature Neuroscience, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.